MYC-Driven Pathways in Breast Cancer Subtypes
The transcription factor MYC (MYC proto-oncogene, bHLH transcription factor) is an essential signaling hub in multiple cellular processes that sustain growth of many types of cancers. MYC regulates expression of RNA, both protein and non-coding, that control central metabolic pathways, cell death, p...
Main Authors: | Yassi Fallah, Janetta Brundage, Paul Allegakoen, Ayesha N. Shajahan-Haq |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2017-07-01
|
Series: | Biomolecules |
Subjects: | |
Online Access: | https://www.mdpi.com/2218-273X/7/3/53 |
Similar Items
-
Polyphenols as Promising Drugs against Main Breast Cancer Signatures
by: María Losada-Echeberría, et al.
Published: (2017-11-01) -
Utilizing immune signatures for breast cancer subtyping in treatment approaches
by: Nguyen Thi Giang An
Published: (2023-06-01) -
Androgen Receptor Expression in ER and PR Negative Breast Cancer—A Study from a Tertiary Hospital in Northern India
by: Sumeet Sidhu, et al.
Published: (2023-10-01) -
Breast Cancer Molecular Subtyping in Practice: A Real-World Study of the APIS Breast Cancer Subtyping Assay in a Consecutive Series of Breast Core Biopsies
by: Silvana Di Palma, et al.
Published: (2024-02-01) -
Clinical and prognostic profile of Her2neu positive (non-luminal) intrinsic breast cancer subtype: comparison with Her2neu positive luminal breast cancers
by: Atif Ali Hashmi, et al.
Published: (2018-08-01)